Akero Therapeutics, Inc. (AKRO)
USD 28.71
(-6.21%)
USD 28.71
(-6.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 29 Thousand | 260 Thousand | 244 Thousand | 213 Thousand | - | - |
| Gross Profit | -29 Thousand | -260 Thousand | -244 Thousand | -213 Thousand | - | - |
| Operating Expenses | 172.87 Million | 115.15 Million | 100.88 Million | 80.15 Million | 45.65 Million | 13.77 Million |
| Selling, General and Administrative Expenses | 31.07 Million | 29.87 Million | 19.12 Million | 15.23 Million | 8.6 Million | 1.89 Million |
| Research and Development Expenses | 141.79 Million | 85.28 Million | 81.75 Million | 64.91 Million | 37.04 Million | 11.88 Million |
| Other Expenses | - | 3.86 Million | 109 Thousand | 947 Thousand | 1.89 Million | -67.93 Million |
| Cost and Expenses | 172.87 Million | 115.15 Million | 100.88 Million | 80.15 Million | 45.65 Million | 13.77 Million |
| Operating Income | -172.87 Million | -115.15 Million | -100.88 Million | -80.15 Million | -45.65 Million | -13.77 Million |
| Interest Expense | 3.09 Million | 739 Thousand | - | - | - | - |
| Income Tax Expense | - | -3.12 Million | -41 Thousand | -17 Thousand | 24 Thousand | -68.09 Million |
| Earnings before Tax | -151.75 Million | -112.03 Million | -100.77 Million | -79.2 Million | -43.75 Million | -81.71 Million |
| Net Income | -151.75 Million | -108.91 Million | -100.73 Million | -79.19 Million | -43.75 Million | -81.71 Million |
| Earnings Per Share Basic | -2.89 | -2.79 | -2.89 | -2.52 | -2.90 | -3.85 |
| Earnings Per Share Diluted | -2.89 | -2.79 | -2.89 | -2.52 | -2.90 | -3.85 |
| Weighted Average Shares Outstanding | 52.56 Million | 38.98 Million | 34.82 Million | 31.46 Million | 15.07 Million | 21.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.56 Million | 38.98 Million | 34.82 Million | 31.46 Million | 15.07 Million | 21.22 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -148.63 Million | -111.03 Million | -100.53 Million | -78.99 Million | -45.65 Million | -68.45 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 284 Thousand | - | - |
| Cost of Revenue | 1000.00 | 1000.00 | 29 Thousand | 2000.00 | 5000.00 | 69 Thousand |
| Gross Profit | -1000.00 | -1000.00 | -29 Thousand | 282 Thousand | -5000.00 | -69 Thousand |
| Operating Expenses | 65.73 Million | 59.95 Million | 172.84 Million | 61.87 Million | 46.61 Million | 35.62 Million |
| Selling, General and Administrative Expenses | 10.41 Million | 9.3 Million | - | 8.47 Million | 7.98 Million | 7.64 Million |
| Research and Development Expenses | 55.32 Million | 50.65 Million | - | 53.39 Million | 38.63 Million | 27.98 Million |
| Other Expenses | -10.41 Million | - | - | -16.62 Million | 7.84 Million | 5.4 Million |
| Cost and Expenses | 65.74 Million | 59.95 Million | 172.87 Million | 61.87 Million | 46.61 Million | 35.62 Million |
| Operating Income | -65.74 Million | -59.95 Million | -172.87 Million | -61.87 Million | -46.61 Million | -35.62 Million |
| Interest Expense | 1.23 Million | 991 Thousand | 3.09 Million | 897 Thousand | 888 Thousand | 857 Thousand |
| Income Tax Expense | 1.00 | -42.27 Thousand | - | -12.52 Million | 8.73 Million | 6.26 Million |
| Earnings before Tax | -55.98 Million | -53.34 Million | -151.75 Million | -55.18 Million | -39.65 Million | -31.08 Million |
| Net Income | -55.98 Million | -53.34 Million | -151.75 Million | -55.18 Million | -39.65 Million | -31.08 Million |
| Earnings Per Share Basic | -0.81 | -0.90 | - | -0.99 | -0.71 | -0.60 |
| Earnings Per Share Diluted | -0.81 | -0.90 | - | -0.99 | -0.71 | -0.60 |
| Weighted Average Shares Outstanding | 69.16 Million | 59.3 Million | 52.56 Million | 55.71 Million | 55.61 Million | 51.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.16 Million | 59.3 Million | 52.56 Million | 55.71 Million | 55.61 Million | 51.86 Million |
| Gross Margin | - | - | - | 0.99 | - | - |
| EBIT Margin | - | - | - | -217.86 | - | - |
| Profit Margin | - | - | - | -194.32 | - | - |
| EBITDA | -65.73 Million | -59.95 Million | - | -61.87 Million | -38.76 Million | -30.21 Million |
| Earnings Before Tax Margin | - | - | - | -217.86 | - | - |
Z74
HMC
NAVKAR
3071
FORR
4194